Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset.
about
Dysregulated axonal RNA translation in amyotrophic lateral sclerosisMolecular motor proteins and amyotrophic lateral sclerosisMitochondrial fission is an acute and adaptive response in injured motor neuronsEmerging mechanisms of molecular pathology in ALSMitochondrial dysfunction in neurodegenerative diseasesExploring new pathways of neurodegeneration in ALS: the role of mitochondria quality controlFUS Interacts with HSP60 to Promote Mitochondrial DamageAxonal transport deficits and degeneration can evolve independently in mouse models of amyotrophic lateral sclerosis.Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALSAbnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models.Endo-MitoEGFP mice: a novel transgenic mouse with fluorescently marked mitochondria in microvascular endothelial cells.Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases.Mechanisms, models and biomarkers in amyotrophic lateral sclerosisMacrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis.ALS-linked misfolded SOD1 species have divergent impacts on mitochondria.A novel phenotype for the dynein heavy chain mutation Loa: altered dendritic morphology, organelle density, and reduced numbers of trigeminal motoneurons.Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS.Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1.Protein misdirection inside and outside motor neurons in Amyotrophic Lateral Sclerosis (ALS): a possible clue for therapeutic strategiesNeurodegeneration as a consequence of failed mitochondrial maintenance.Misfolded SOD1 and ALS: zeroing in on mitochondria.Review: Axon pathology in age-related neurodegenerative disorders.Amyotrophic lateral sclerosis: new genes, new models, and new mechanisms.Selective vulnerability of motoneuron and perturbed mitochondrial calcium homeostasis in amyotrophic lateral sclerosis: implications for motoneurons specific calcium dysregulation.Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration.Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research?Motoneuron Disease: Basic Science.Mitochondrial quality control in amyotrophic lateral sclerosis: towards a common pathway?Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosisAtomic structure of a toxic, oligomeric segment of SOD1 linked to amyotrophic lateral sclerosis (ALS).Constitutive downregulation protein kinase C epsilon in hSOD1G93A astrocytes influences mGluR5 signaling and the regulation of glutamate uptake.The mito::mKate2 mouse: A far-red fluorescent reporter mouse line for tracking mitochondrial dynamics in vivo.Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis.Phrenic Motor Neuron Loss in Aged Rats.Releasing Syntaphilin Removes Stressed Mitochondria from Axons Independent of Mitophagy under Pathophysiological Conditions.The voltage-gated calcium channel blocker lomerizine is neuroprotective in motor neurons expressing mutant SOD1, but not TDP-43.Impact of aging on diaphragm muscle function in male and female Fischer 344 rats.Amyotrophic lateral sclerosis
P2860
Q26753110-FF6C4FFA-01EF-4A3A-A693-43B8B6805783Q26820831-73DA70D5-7A63-495B-8072-2FC93AE0C17BQ27335694-6895E0BA-AC83-4879-AB47-9270E5EAAC1DQ28081239-43D2DE71-5F94-4306-B523-4FFCC7AE0143Q28387647-C99CB3E3-6804-4E24-87D4-662BC4EB1E8AQ28391199-BC5330B6-133E-42C2-B810-AC47D498F6F8Q28547727-5589DEAC-CF7B-45B3-839B-30E399AD5290Q30511133-CE3C3191-9DBB-4DF6-94BD-37A44473757AQ30534614-2CE191C7-0D8B-4EC8-8694-73DBC9137539Q30572264-2424B900-E781-46A3-A649-867A671BE20FQ31138043-2B29284D-6D54-4DBA-97F2-A40D337A2D17Q33845021-E9C414D3-8FFB-4035-8356-5175F36D7CADQ34344992-230027AC-00DC-4F38-8F0E-95A487DE4929Q35365484-DD169676-6162-4982-B326-639267D65806Q35899260-93A65306-AF42-4D44-A327-8E6B4AFF4824Q36842266-0AE4A3A0-0032-49FA-9108-3E523F26CB8AQ36999640-883D4C97-337B-4851-B6BD-FFEEF7E118B6Q37247621-1B506E7B-B812-4AAA-8E20-774526C8EC46Q37313745-C826ADA6-49E9-48CC-8030-FFF268BDBF71Q37954610-4C2718A9-F093-44C4-9EE3-1192902E0892Q37965012-1BAB4727-B80F-428C-ACFF-22322562F7A9Q37999478-FFD6427F-9672-43E5-8D07-FD58C4822599Q38050513-1114E167-14E3-4CB5-9A05-1564100279C2Q38363759-FE9F0D89-32D3-49C2-9916-5A0EA7780430Q38521756-C8E16160-8CAC-4AAB-9155-56C65B175ADCQ38570991-2FE07AE0-689A-4E86-AAE3-33805ED0BEE3Q39149919-B3485EFF-2731-4E0E-A668-9492AB6F1E97Q39413091-7EF1BC46-BF92-4E69-BB73-329CD7D6F795Q41429779-C53B80F0-E911-4B4E-A31C-55EB4C57A1E8Q41842786-8C8A4810-22A4-4EDD-BA51-72782B209CA9Q45953477-3F266CF0-6F67-4612-8D9F-0E725D5D5415Q47266093-5A4E917A-DC5E-414D-A86F-5DFF21428FB3Q47291222-D1CB9E70-665E-4E08-9549-AA3F19BD3162Q48240848-D33627C9-DB21-4F1D-A603-4148614DF37BQ50140823-68EEA48A-F3E4-4207-86C4-DD7F004932CCQ51019981-5FBDA0C8-4A40-460E-8834-C9AB62806D4BQ52649242-300D1119-970D-4FAD-B9D4-D947D444404BQ55653478-785473A0-87DF-42BA-979F-BD35826D296CQ56531747-4E834968-4C26-4A83-8F67-C4D4A0912E9B
P2860
Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Misfolded SOD1 associated with ...... ution prior to clinical onset.
@ast
Misfolded SOD1 associated with ...... ution prior to clinical onset.
@en
type
label
Misfolded SOD1 associated with ...... ution prior to clinical onset.
@ast
Misfolded SOD1 associated with ...... ution prior to clinical onset.
@en
prefLabel
Misfolded SOD1 associated with ...... ution prior to clinical onset.
@ast
Misfolded SOD1 associated with ...... ution prior to clinical onset.
@en
P2093
P2860
P1433
P1476
Misfolded SOD1 associated with ...... bution prior to clinical onset
@en
P2093
Andre Zandona
Christian S Lobsiger
Christine Vande Velde
Jean-Pierre Julien
Karli K McDonald
Melissa McAlonis-Downes
Samar Bel Hadj
Sameer B Shah
Yasmin Boukhedimi
P2860
P304
P356
10.1371/JOURNAL.PONE.0022031
P407
P577
2011-07-11T00:00:00Z